| HGNC Family | Protein arginine methyltransferases (PRMT) |
| Name | protein arginine methyltransferase 1 |
| Description | This gene encodes a member of the protein arginine N-methyltransferase (PRMT) family. Post-translational modification of target proteins by PRMTs plays an important regulatory role in many biological processes, whereby PRMTs methylate arginine residues by transferring methyl groups from S-adenosyl-L-methionine to terminal guanidino nitrogen atoms. The encoded protein is a type I PRMT and is responsible for the majority of cellular arginine methylation activity. Increased expression of this gene may play a role in many types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 5. [provided by RefSeq, Dec 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nProtein arginine methyltransferase 1 (PRMT1) is the predominant enzyme catalyzing asymmetric dimethylation of arginine residues on both histone and non‐histone substrates. Through this activity, PRMT1 regulates chromatin structure, transcriptional activation and repression, RNA processing, and DNA repair. For example, it methylates histone H4 at arginine 3 (H4R3me2a) to create epigenetic marks that prevent heterochromatin spread and facilitate transcription, and it modulates the function of key transcription factors (e.g., ERα, RUNX1) as well as proteins central to DNA damage checkpoint responses (e.g., MRE11, 53BP1). In addition, PRMT1 is responsible for the majority of asymmetric dimethylarginine formation, and its expression is frequently elevated in various cancers, suggesting a role as a critical regulator of fundamental cellular processes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn oncogenic contexts, PRMT1 exerts multifaceted roles by modulating transcriptional complexes and signaling cascades that promote malignant transformation, proliferation, and metastasis. It participates in oncogenic transcription complexes—such as those involving mixed lineage leukemia (MLL) fusions and AML1‐ETO—by depositing H4R3 methyl marks and altering co-regulator binding, thereby enhancing self-renewal of leukemic cells. Furthermore, PRMT1-mediated methylation of key proteins including RBM15, EGFR, Twist1, and BAD has been shown to regulate alternative RNA splicing, enhance receptor–ligand interactions and dimerization, drive epithelial–mesenchymal transition (EMT), and block pro-survival kinase phosphorylation. This diverse modulation is central to oncogenesis in cancers such as breast, lung, and acute myeloid leukemia, where even specific PRMT1 isoforms have been linked to altered cell invasion and survival. Moreover, PRMT1-dependent methylation of FLT3 in FLT3-ITD+ leukemia cells underscores its role in maintaining oncogenic signaling independent of kinase activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in tumorigenesis, PRMT1 influences protein–protein interactions, subcellular localization and stress responses in both neuronal and viral settings. It methylates RNA-binding proteins such as FUS/TLS, FMRP, and EWS to regulate their nucleo–cytoplasmic shuttling and aggregation properties—events that are central to the pathogenesis of neurodegenerative diseases. In addition, PRMT1 modulates the activity of nuclear receptors like PXR and alters viral protein function via methylation of HBx and LANA, thereby affecting viral transcription and latency. Its activity also impacts mitochondrial Ca²⁺ uptake by methylating MICU1 and collaborates with cofactors (e.g., hCAF1) and stress granule components to fine-tune RNA metabolism. Such diverse regulatory functions highlight PRMT1’s importance in multiple cellular contexts, including maintenance of genomic stability and response to environmental stress"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "36"}]}, {"type": "t", "text": ">.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, targeted inhibition studies in acute myeloid leukemia models further underscore the therapeutic potential of modulating PRMT1 activity to eradicate cancer cell survival pathways, with strategies combining PRMT1 inhibition alongside tyrosine kinase inhibitors showing promise for eliminating resistant leukemic clones."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Masanori Yoshimatsu, Gouji Toyokawa, Shinya Hayami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.25366"}], "href": "https://doi.org/10.1002/ijc.25366"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20473859"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20473859"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ngai Cheung, Li Chong Chan, Alex Thompson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein arginine-methyltransferase-dependent oncogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1642"}], "href": "https://doi.org/10.1038/ncb1642"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17891136"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17891136"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Muriel Le Romancer, Isabelle Treilleux, Nicolas Leconte, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of estrogen rapid signaling through arginine methylation by PRMT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2008.05.025"}], "href": "https://doi.org/10.1016/j.molcel.2008.05.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18657504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18657504"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "François-Michel Boisvert, Ugo Déry, Jean-Yves Masson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1279805"}], "href": "https://doi.org/10.1101/gad.1279805"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15741314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15741314"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yanzhong Yang, Yue Lu, Alexsandra Espejo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TDRD3 is an effector molecule for arginine-methylated histone marks."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2010.11.024"}], "href": "https://doi.org/10.1016/j.molcel.2010.11.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21172665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21172665"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Surbhi Dhar, Vidyasiri Vemulapalli, Alexander N Patananan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep01311"}], "href": "https://doi.org/10.1038/srep01311"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23419748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23419748"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Thomas B Nicholson, Taiping Chen, Stéphane Richard "}, {"type": "b", "children": [{"type": "t", "text": "The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.phrs.2009.07.006"}], "href": "https://doi.org/10.1016/j.phrs.2009.07.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19643181"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19643181"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "K Mathioudaki, A Papadokostopoulou, A Scorilas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The PRMT1 gene expression pattern in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6604807"}], "href": "https://doi.org/10.1038/sj.bjc.6604807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19078953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19078953"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Han Wei, Rasika Mundade, Kevin C Lange, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein arginine methylation of non-histone proteins and its role in diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.27353"}], "href": "https://doi.org/10.4161/cc.27353"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24296620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24296620"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ngai Cheung, Tsz Kan Fung, Bernd B Zeisig, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2015.12.007"}], "href": "https://doi.org/10.1016/j.ccell.2015.12.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26766589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26766589"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Li Zhang, Ngoc-Tung Tran, Hairui Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.07938"}], "href": "https://doi.org/10.7554/eLife.07938"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26575292"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26575292"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hsin-Wei Liao, Jung-Mao Hsu, Weiya Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI82826"}], "href": "https://doi.org/10.1172/JCI82826"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26571401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26571401"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Wei-Jong Shia, Akiko J Okumura, Ming Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2011-04-347476"}], "href": "https://doi.org/10.1182/blood-2011-04-347476"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22498736"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22498736"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Antje Ostareck-Lederer, Dirk H Ostareck, Karl P Rucknagel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M513053200"}], "href": "https://doi.org/10.1074/jbc.M513053200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16492668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16492668"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Sreedevi Avasarala, Michelle Van Scoyk, Manoj Kumar Karuppusamy Rathinam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.636050"}], "href": "https://doi.org/10.1074/jbc.M114.636050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25847239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25847239"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Whitney L Wooderchak, Tianzhu Zang, Zhaohui Sunny Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the \"RGG\" paradigm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi800984s"}], "href": "https://doi.org/10.1021/bi800984s"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18700728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18700728"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jun-ichi Sakamaki, Hiroaki Daitoku, Katsuya Ueno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1015328108"}], "href": "https://doi.org/10.1073/pnas.1015328108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21444773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21444773"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yanyan Gao, Yaping Zhao, Juechao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep19874"}], "href": "https://doi.org/10.1038/srep19874"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26813495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26813495"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Atsushi Yamaguchi, Keiko Kitajo "}, {"type": "b", "children": [{"type": "t", "text": "The effect of PRMT1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of FUS/TLS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0049267"}], "href": "https://doi.org/10.1371/journal.pone.0049267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23152885"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23152885"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yannis Robin-Lespinasse, Stéphanie Sentis, Chloé Kolytcheff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "hCAF1, a new regulator of PRMT1-dependent arginine methylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.03357"}], "href": "https://doi.org/10.1242/jcs.03357"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17264152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17264152"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xin He, Yinghui Zhu, Yi-Chun Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.2019001282"}], "href": "https://doi.org/10.1182/blood.2019001282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31217189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31217189"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Miranda L Tradewell, Zhenbao Yu, Michael Tibshirani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddr448"}], "href": "https://doi.org/10.1093/hmg/ddr448"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21965298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21965298"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ernest Blackwell, Xing Zhang, Stephanie Ceman "}, {"type": "b", "children": [{"type": "t", "text": "Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddq007"}], "href": "https://doi.org/10.1093/hmg/ddq007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20064924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20064924"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Frank Herrmann, Jaeho Lee, Mark T Bedford, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M502458200"}], "href": "https://doi.org/10.1074/jbc.M502458200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16159886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16159886"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Shirine Benhenda, Aurélie Ducroux, Lise Rivière, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.02574-12"}], "href": "https://doi.org/10.1128/JVI.02574-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23388725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23388725"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Natsumi Araya, Hideaki Hiraga, Koichiro Kako, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2005.02.018"}], "href": "https://doi.org/10.1016/j.bbrc.2005.02.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15737635"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15737635"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ying Xie, Sui Ke, Nengtai Ouyang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M806193200"}], "href": "https://doi.org/10.1074/jbc.M806193200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19144646"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19144646"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Mel Campbell, Pei-Ching Chang, Steve Huerta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.289496"}], "href": "https://doi.org/10.1074/jbc.M111.289496"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22179613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22179613"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Melissa M Adams, Bin Wang, Zhenfang Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "53BP1 oligomerization is independent of its methylation by PRMT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.4.12.2282"}], "href": "https://doi.org/10.4161/cc.4.12.2282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16294047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16294047"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Marc Suárez-Calvet, Manuela Neumann, Thomas Arzberger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00401-016-1544-2"}], "href": "https://doi.org/10.1007/s00401-016-1544-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26895297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26895297"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Bing Yao, Tao Gui, Xiangwei Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13073-021-00871-5"}], "href": "https://doi.org/10.1186/s13073-021-00871-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33853662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33853662"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "B Cha, W Kim, Y K Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.610"}], "href": "https://doi.org/10.1038/onc.2010.610"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21242974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21242974"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "R Mitchell Baldwin, Alan Morettin, Genevieve Paris, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.22871"}], "href": "https://doi.org/10.4161/cc.22871"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23187807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23187807"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Corina T Madreiter-Sokolowski, Christiane Klec, Warisara Parichatikanond, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRMT1-mediated methylation of MICU1 determines the UCP2/3 dependency of mitochondrial Ca(2+) uptake in immortalized cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms12897"}], "href": "https://doi.org/10.1038/ncomms12897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27642082"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27642082"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Rania Elakoum, Guillaume Gauchotte, Abderrahim Oussalah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochimie (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biochi.2013.10.021"}], "href": "https://doi.org/10.1016/j.biochi.2013.10.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24211191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24211191"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Frank Herrmann, Maike Bossert, Andrea Schwander, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arginine methylation of scaffold attachment factor A by heterogeneous nuclear ribonucleoprotein particle-associated PRMT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M407332200"}], "href": "https://doi.org/10.1074/jbc.M407332200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15364944"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15364944"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Chuyu Huang, Yan Chen, Huaiqian Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UBAP2L arginine methylation by PRMT1 modulates stress granule assembly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-019-0350-5"}], "href": "https://doi.org/10.1038/s41418-019-0350-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31114027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31114027"}]}]}]}
|
| Synonyms | HRMT1L2, ANM1, IR1B4 |
| Proteins | ANM1_HUMAN |
| NCBI Gene ID | 3276 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PRMT1 has 11,875 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 132 datasets.
Click the + buttons to view associations for PRMT1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PRMT1 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRMT1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRMT1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRMT1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PRMT1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PRMT1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRMT1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving PRMT1 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PRMT1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRMT1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRMT1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRMT1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PRMT1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PRMT1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PRMT1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRMT1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PRMT1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PRMT1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing PRMT1 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRMT1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PRMT1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PRMT1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PRMT1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PRMT1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing PRMT1 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRMT1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PRMT1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PRMT1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PRMT1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PRMT1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PRMT1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PRMT1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PRMT1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PRMT1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PRMT1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PRMT1 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRMT1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRMT1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PRMT1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PRMT1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PRMT1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PRMT1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PRMT1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PRMT1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PRMT1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRMT1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PRMT1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRMT1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PRMT1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PRMT1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PRMT1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PRMT1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PRMT1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PRMT1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing PRMT1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PRMT1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PRMT1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PRMT1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PRMT1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PRMT1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PRMT1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRMT1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding PRMT1 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PRMT1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PRMT1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PRMT1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRMT1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PRMT1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PRMT1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PRMT1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PRMT1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRMT1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PRMT1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with PRMT1 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PRMT1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PRMT1 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PRMT1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PRMT1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PRMT1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PRMT1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate PRMT1 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRMT1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRMT1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PRMT1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PRMT1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PRMT1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PRMT1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRMT1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PRMT1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PRMT1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PRMT1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PRMT1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PRMT1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PRMT1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for PRMT1 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PRMT1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for PRMT1 protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PRMT1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing PRMT1 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| NURSA Protein-Protein Interactions | interacting proteins for PRMT1 from the NURSA Protein-Protein Interactions dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PRMT1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRMT1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PRMT1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PRMT1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PRMT1 protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving PRMT1 protein from the PID Pathways dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of PRMT1 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving PRMT1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PRMT1 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRMT1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRMT1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRMT1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PRMT1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRMT1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRMT1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PRMT1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PRMT1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PRMT1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PRMT1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PRMT1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PRMT1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PRMT1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PRMT1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRMT1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PRMT1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRMT1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PRMT1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PRMT1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for PRMT1 from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with PRMT1 from the Virus MINT Protein-Virus Interactions dataset. | |
| WikiPathways Pathways 2014 | pathways involving PRMT1 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PRMT1 protein from the WikiPathways Pathways 2024 dataset. | |